Identifying Predictors of First-Line Subcutaneous TNF-Inhibitor Persistence in Patients with Inflammatory Arthritis: A Decision Tree Analysis by Indication

INTRODUCTION: Treatment persistence is a proxy for efficacy, safety and patient satisfaction, and a switch in treatment or treatment discontinuation has been associated with increased indirect and direct costs in inflammatory arthritis (IA). Hence, there are both clinical and economic incentives for...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalén, Johan, Svedbom, Axel, Hernlund, Emma, Olofsson, Tor, Black, Christopher M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499966/
https://www.ncbi.nlm.nih.gov/pubmed/37599341
http://dx.doi.org/10.1007/s12325-023-02600-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499966/
https://www.ncbi.nlm.nih.gov/pubmed/37599341
http://dx.doi.org/10.1007/s12325-023-02600-3

Ejemplares similares